BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//N2 Canada - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:N2 Canada
X-ORIGINAL-URL:https://n2canada.ca
X-WR-CALDESC:Events for N2 Canada
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20240917T120000
DTEND;TZID=America/Vancouver:20240917T130000
DTSTAMP:20240816T192348Z
CREATED:20240816T192348Z
LAST-MODIFIED:20240816T192348Z
UID:13465-1726574400-1726578000@n2canada.ca
SUMMARY:WHO Guidance for Best Practices for Clinical Trials
DESCRIPTION:Clinical trials have a central role in generating the evidence needed to inform the development and implementation of health interventions. This is because they can reliably determine whether a health intervention has any effect by ensuring that any biases or random errors inherent in the study design are small with respect to the expected treatment effect. The results have been transformative in advancing global public health.  \nThe intent of the ‘World Health Organization guidance for best practices for clinical trials’ document is to support implementation of universal ethical and scientific standards and strengthen the clinical trial ecosystem\, with a focus on under-represented populations. It is also complementary to other good clinical practice initiatives.  \nJoin us for an overview presentation on the WHO document which spans all regions and nations and is applicable across all health product lines: any design\, health intervention\, purpose\, setting and role.  \nTarget audience \nAny clinical trial staff member whose work is related to clinical trials in any way. This includes in planning\, conduct\, analysis\, oversight\, interpretation\, education and funding of all clinical trials in which randomization is used to assess the effects of any health intervention for any purpose in any setting.  \nLearning objectives \nThe learner will be able to:  \n\nhave an awareness of the main issues and steps required to facilitate good clinical trials and reduce waste\, \nidentify the qualities of a well-designed\, well-implemented and clinically relevant trial\, \nuse a framework and tools to self-evaluate whether a team has adequate infrastructure (physical and trial personnel) required to conduct an efficient high-quality trial\, \nlist the competencies that should be demonstrated by a clinical research team to undertake a successful study\, \nlead a discussion on the strenuous efforts needed to be made\, to recruit diverse populations to clinical trials.\n \n\nPresenter\n \n  \n  \n  \n  \n  \n  \nJean Smart\, PhD\, MGH\, MIDS \nRegulatory Affairs & Quality Officer\, Clinical Trials BC
URL:https://n2canada.ca/event/who-guidance-for-best-practices-for-clinical-trials/
LOCATION:Zoom
CATEGORIES:N2 Member Events
ATTACH;FMTTYPE=image/png:https://n2canada.ca/wp-content/uploads/2024/08/Event-Posters-for-Website.png
END:VEVENT
END:VCALENDAR